ID: ALA3604788
Chembl Id: CHEMBL3604788
PubChem CID: 122186025
Max Phase: Preclinical
Molecular Formula: C17H10F3NO
Molecular Weight: 301.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1c(F)cc(-c2cnccc2-c2ccc(F)cc2)cc1F
Standard InChI: InChI=1S/C17H10F3NO/c18-12-3-1-10(2-4-12)13-5-6-21-9-14(13)11-7-15(19)17(22)16(20)8-11/h1-9,22H
Standard InChI Key: WEXZHJRBQNKEKT-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 301.27 | Molecular Weight (Monoisotopic): 301.0714 | AlogP: 4.54 | #Rotatable Bonds: 2 |
| Polar Surface Area: 33.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 7.35 | CX Basic pKa: 4.89 | CX LogP: 4.17 | CX LogD: 3.85 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.75 | Np Likeness Score: -0.48 |
| 1. Jain R, Mathur M, Lan J, Costales A, Atallah G, Ramurthy S, Subramanian S, Setti L, Feucht P, Warne B, Doyle L, Basham S, Jefferson AB, Lindvall M, Appleton BA, Shafer CM.. (2015) Discovery of Potent and Selective RSK Inhibitors as Biological Probes., 58 (17): [PMID:26270416] [10.1021/acs.jmedchem.5b00450] |
Source(1):
